MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, PHGE has $3,251K in assets. $4,132K in debts. $1,168K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
124.36%
Quick Ratio
124.36%
Cash Ratio
47.73%
Debt to Asset Ratio
127.10%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • In-process research and developm...
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Preferred stock, 0.0001 par valu...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Restricted cash
-595 985 979
Property and equipment, held for sale
-157 --
Cash and cash equivalents
1,168 4,360 6,923 14,046
Other current assets
1,875 463 954 1,610
Total current assets
3,043 5,575 8,862 16,635
Non-current restricted cash
--161 161
Operating lease right-of-use assets
--2,091 4,959
Property and equipment, net
--3,004 4,245
In-process research and development (ipr&d) asset
208 208 12,050 12,050
Total non-current assets
-208 17,306 21,415
Total assets
3,251 5,783 26,168 38,050
Current portion of lease liabilities
-1,436 1,296 1,233
Trade account payables
720 3,120 1,508 2,178
Balance due biomx ltd
1,254 ---
Other account payables
473 1,823 2,422 2,851
Total current liabilities
2,447 6,379 5,226 6,262
Operating lease liabilities, net of current portion
--5,287 8,143
Other liabilities
--34 80
Warrants
1,685 706 5,135 4,405
Total non-current liabilities
1,685 706 10,456 12,628
Total liabilities
4,132 ---
Preferred stock, 0.0001 par value authorized - 1,000,000 shares as of march 31, 2026 and december 31, 2025. issued and outstanding 147,512 as of march 31, 2026 and 147,512 shares as of december 31, 2025
18,617 18,617 18,617 18,645
Common stock, 0.0001 par value (common stock) authorized - 750,000,000 shares as of march 31, 2026 and december 31, 2025. issued and outstanding 6,543,703 and 1,593,703 as of march 31, 2026 and december 31, 2025, respectively
7 7 7 7
Receivables on account of shares
3,300 ---
Additional paid-in capital
219,831 196,970 195,421 194,901
Accumulated deficit
-236,036 -216,896 -203,559 -194,393
Total capital deficiency
-881 -1,302 10,486 19,160
Total liabilities and capital deficiency
3,251 5,783 26,168 38,050
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Other current assets$1,875K Cash and cashequivalents$1,168K Total current assets$3,043K In-process research anddevelopment (ipr&d) asset$208K Total assets$3,251K Accumulated deficit-$236,036K Receivables on account ofshares$3,300K Total liabilities andcapital deficiency$3,251K Total capitaldeficiency-$881K Additional paid-in capital$219,831K Preferred stock, 0.0001par value...$18,617K Common stock, 0.0001par value (common...$7K Total liabilities$4,132K Total currentliabilities$2,447K Total non-currentliabilities$1,685K Balance due biomx ltd$1,254K Trade accountpayables$720K Other accountpayables$473K Warrants$1,685K

BiomX Inc. (PHGE)

BiomX Inc. (PHGE)